期刊文献+

网织血小板百分比增加与阿司匹林抵抗的关系 被引量:4

Association between Increased Reticulated Platelets Percentage and Aspirin Resistance
原文传递
导出
摘要 目的:以网织血小板(RP)百分比代表血小板更新率,研究RP百分比与阿司匹林抵抗(AR)发生率之间的关系,阐明血小板更新率对AR的影响。方法:选取80名服用阿司匹林的患者,测定其服用阿司匹林(100mg.d-1)≥7d后的RP百分比以及在花生四烯酸(AA)、二磷酸腺苷(ADP)诱导下的血小板聚集率。将患者分为AR组、阿司匹林半抵抗(ASR)组、阿司匹林敏感(AS)组,比较AR、ASR、AS3组之间RP百分比的差异是否有统计学意义。结果:AR、ASR、AS3组RP百分比分别为(4.11±2.62)%、(2.23±1.79)%、(2.18±1.24)%,AR、AS组之间RP百分比有显著性差异(P<0.05),AR、ASR组之间RP百分比有显著性差异(P<0.05),ASR、AS组之间RP百分比无显著性差异(P>0.05)。结论:血小板更新率增加可能会导致AR,冠心病患者可能需要在1天内多次服用阿司匹林抗血小板治疗,或将阿司匹林改为控释或缓释剂型,建议对这些疗法的安全性和有效性进行临床试验来验证。 OBJECTIVE: To study the association between the reticulated platelets (RP) percentage and aspirin resistance (AR) with the percentage of reticulated platelets in whole blood representing the platelets turnover rate to illuminate the influence of platelets turnover rate on AR. METHODS: The RP percentage and arachidonic acid (AA) and adenosine diphosphate(ADP) - induced platelet aggregation in 80 patients after receiving aspirin (100 mg· day) for no less than 7 days were determined. The patients were divided into AR group, aspirin semi - resistance (ASR) group, and aspirin sensitive (AS) group, and the RP percentage in the three groups were compared. RESULTS: RP percentages in AR, ASR, and AS groups were (4.11 ± 2.62) %, (2.23 ± 1.79) %, and (2.18 ± 1.24) %, respectively, showing signficant differneces between AR group and AS group (P〈0.05) and between AR group and ASR group (P〈0.05), but the difference of RP percentage between ASR group and AS group was not significant (P 〉0.05). CONCLUSION: Increased platelets turnover may induce AR, therefore, the patients with coronary artery disease should receive aspirn for multiple daily (antiplatelet therapy) or to take controlled release or sustained release aspirin. The safety and efficacy of these therapies should be confirmed in clinical trials.
出处 《中国药房》 CAS CSCD 北大核心 2008年第29期2280-2282,共3页 China Pharmacy
基金 上海市卫生局基金资助项目(044018)
关键词 阿司匹林抵抗 血小板更新率 网织血小板 Aspirin resistance Platelet turnover rate Reticulated platelets
  • 相关文献

参考文献14

  • 1Bhatt DL,Topol EJ .Scientific and therapeutic advances in antiplatelet therapy[J] . Nature Rev Drug Discov , 2003,2(1) : 15.
  • 2Gum PA, Kottke- Marchant K, Welsh PA, et al. A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease[J ] . J Am Coll Cardiol , 2003 ,41(6):961.
  • 3Eikelboom JW, Hirsh J, Weitz JI, et al . Aspirin- resistant thromboxane biosynthesis and the risk of myocardial infarction , stroke , or cardiovascular death in patients at high risk for cardiovascular events[J] Circulation, 2002,105(14) : 1 650.
  • 4Hankey OJ, Eikelboom JW. Aspirin resistance[J] . Lancet, 2006,367(9 510) : 606.
  • 5Rinder HM, Schuster JE, Rinder CS, et al. Correlation of thrombosis with increased platelet turnover in thromboeytosis[J ]. Blood, 1998,91(4) : 1 288.
  • 6王春波,胡大一,史旭波,朱正炎,朱晶岩,杨进刚.服用小剂量阿司匹林患者的阿司匹林抵抗[J].中国危重病急救医学,2006,18(4):219-223. 被引量:34
  • 7Zimmermann N, Wenk A, Kim U, et al. Functional and biochemical evaluation of platelet aspirin resistance after coronary artery bypass surgery[J] . Circulation, 2003,108(5) : 542.
  • 8Rocca B, Secchiero P, Ciabattoni G, et al. Cyelooxygenase- 2 expression is induced during human megakaryopoiesis and characterizes newly formed platelets [J]. Proc Natl Acad Sci USA ,2002, 99(11): 7 634.
  • 9Guthikonda S, Lev El, Patel R, et al. Reticulated platelets and uninhibited COX - 1 and COX - 2 decrease the antiplatelet effects of aspirin[J]. J Thromb Haemost, 2007,5(3) : 490.
  • 10The CURE Investigatiors. Effects of clopidogrel in addition to asipirin in patients with acute coronary syndromes without ST- segment elevation[J] . N Engl J Med, 2001,345(7) : 494.

二级参考文献40

  • 1[1]Gerschutz G P, Bhatt D L. The Clopidogrel in Unstable Angina to Prevent Recurrent Events (CURE) study: to what extent should the results be generalizable? Am Heart J,2003, 145:595-601.
  • 2[2]CAPRIE steering committee. A randomized, blinded, trial of clopidogrel versus aspirin in patients at risk of ischemic events(CAPRIE).Lancet,1996,348:1329-1339.
  • 3[4]Tarjan J, Salamon A, Jager R, et al. The rate of acetylsalicylic acid non-respondents among patients hospitalized for acute coronary disease, previously undergoing secondary salicylic acid prophylaxis. Orv Hetil, 1999, 140:2339-2343.
  • 4[5]Friend M, Vucenik I, Miller M. Research pointers: Platelet responsiveness to aspirin in patients with hyperlipidaemia. BMJ,2003, 326:82-83.
  • 5[6]Yusuf S, Mehta S R, Zhao F, et al. Early and late effects of clopidogrel in patients with acute coronary syndromes. Circulation, 2003, 107:966-972.
  • 6Patricia AG, Kandice KM, Emilio DP, et al. Profile and prevalence of aspirin resistance in patients with cardiovascular disease. Am J Cardiol,2001,88:230.
  • 7Grotemeyer KH,Scharafinski HW, Husstedt IW. Two-year follow-up of aspirin responder and aspirin non-responder. A pilot study including 180 post-stroke patients. Thromb Res, 1993,71:397-403.
  • 8Muller MR, Salat A, Stangl P, et al. Variable platelet response to low-dose aspirin and the risk of limb deterioration in patients submitted to peripheral arterial angioplasty. Thromb Haemoost,1997,78:1003-1007.
  • 9Eikelboom JW, Hirsh J, Weitz JI, et al. Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients with high risk for cardiovascular events. Circulation, 2002,105:1650-1655.
  • 10Gum PA,Kottke-Marchant K,Welsh PA, et al.A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease. J Am Coll Cardiol, 2003,41:961-965.

共引文献76

同被引文献53

  • 1张鹙月,刘玉锦,张敏.缺血性脑卒中阿司匹林抵抗危险因素的Meta分析[J].心脑血管病防治,2022,22(6):32-37. 被引量:7
  • 2赵丽筠,谢思勤,王炜.口服小剂量阿司匹林致上消化道出血141例的文献分析[J].海南医学,2005,16(3):102-103. 被引量:5
  • 3Expert panel on detection,evaluation and treatment of high blood cholesterol in adults.Executive summary of the third report of the national cholesterol education program (ncep) expert panel on detection,evaluation,and treatment of high blood cholesterol in adults (adult treatment panel Ⅲ)[J].JAMA,2001,285:2 486 -2 497.
  • 4Pulcinelli FM,Biasucci LM,Riondino S,et al.COX-1 sensitivity and thromboxane A2 production in type 1 and type 2 diabetic patients under chronic aspirin treatment[J].European Heart Journal,2009,30:1 279-1 286.
  • 5Watala C,Colanskij C,Waczulikova L,et al.High glucose contributes to aspirin insensitivity in streptozotocin -diabetic rats:a mul-tiparametric aggregation srudy[J].Blood Coagulation and Fibrinoly-sis,2006,17(2):113-124.
  • 6Watala C,Pluta J,Golanski J,et al.Increased protein glycation in diabetes mellitus is associated with decreased aspirin-mediated protein acetylation and reduced sensitivity of blood platelets to aspirin[J].J Mol Med,2005,83(2):148-158.
  • 7Watala C,GolanskiC,Pluta J,et al.Reduced sensitivity of platelets from type 2 diabetic patients to acetylsalicylic acid (aspirin)-its relation to metabolic control[J].Thrombosis Research,2004,113 (2):101-113.
  • 8Weber AA,Przytulski B,Schanz A,et al.Towards a definition of aspirin resistance:a typological approach[J].Platelets,2002,13(1):37-40.
  • 9Hangaishi M,Taguchi J,Miyata T,et al.Increased Aggregation of Human Platelets Produced by Advanced Glycation End Products in Vitro[J].Biochemical and biophysical research communications,1998,248(2):285-292.
  • 10Gresner P,Dolnik M.Increased blood plasma hydrolysis of acetylsalicylic acid in type 2 diabeticpatients:A role of plasma esterases[J].Biochimica et Biophysica Acta,2006,1760 (2):207 -215.

引证文献4

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部